Citations for
1BGN, SEMD6
BGN Mutations in X-Linked Spondyloepimetaphyseal Dysplasia.
Cho SY, Bae JS, Kim NK, Forzano F, Girisha KM, Baldo C, Faravelli F, Cho TJ, Kim D, Lee KY, Ikegawa S, Shim JS, Ko AR, Miyake N, Nishimura G, Superti-Furga A, Spranger J, Kim OH, Park WY, Jin DK.
Am J Hum Genet 98(6):1243-8. doi: 10.1016/j.ajhg.2016.04.004. Epub 2016 May 26. 2016
2BGN, DCN
The small leucine-rich proteoglycan BGN accumulates in CADASIL and binds to NOTCH3.
Zhang X, Lee SJ, Young MF, Wang MM.
Transl Stroke Res 6(2):148-55. doi: 10.1007/s12975-014-0379-1. Epub 2015 Jan 13. 2015
3BGN, FGF1, FGFR3
Biglycan is a novel binding partner of fibroblast growth factor receptor 3c (FGFR3c) in the human testis.
Winge SB, Nielsen J, Jørgensen A, Owczarek S, Ewen KA, Nielsen JE, Juul A, Berezin V, Rajpert-De Meyts E.
Mol Cell Endocrinol 399:235-43. doi: 10.1016/j.mce.2014.09.018. Epub 2014 Sep 23. 2015
4BGN
The BGN and ACAN genes and carpal tunnel syndrome.
Burger MC, De Wet H, Collins M.
Gene 551(2):160-6. doi: 10.1016/j.gene.2014.08.051. Epub 2014 Aug 27. 2014
5BGN
Biglycan deficiency: increased aortic aneurysm formation and lack of atheroprotection.
Tang T, Thompson JC, Wilson PG, Yoder MH, Müeller J, Fischer JW, Williams KJ, Tannock LR.
J Mol Cell Cardiol 75:174-80. doi: 10.1016/j.yjmcc.2014.07.014. Epub 2014 Aug 2. 2014
6BGN
Biglycan modulates angiogenesis and bone formation during fracture healing.
Berendsen AD, Pinnow EL, Maeda A, Brown AC, McCartney-Francis N, Kram V, Owens RT, Robey PG, Holmbeck K, de Castro LF, Kilts TM, Young MF.
Matrix Biol 35:223-31. doi: 10.1016/j.matbio.2013.12.004. Epub 2013 Dec 25. 2014
7BGN
Biglycan and decorin differentially regulate signaling in the fetal membranes.
Wu Z, Horgan CE, Carr O, Owens RT, Iozzo RV, Lechner BE.
Matrix Biol 35:266-75. doi: 10.1016/j.matbio.2013.12.006. Epub 2013 Dec 25. 2014
8BGN, DCN
The tendon injury response is influenced by decorin and biglycan.
Dunkman AA, Buckley MR, Mienaltowski MJ, Adams SM, Thomas SJ, Satchell L, Kumar A, Pathmanathan L, Beason DP, Iozzo RV, Birk DE, Soslowsky LJ.
Ann Biomed Eng 42(3):619-30. doi: 10.1007/s10439-013-0915-2. Epub 2013 Sep 27. 2014
9BGN
Mechanical, compositional, and structural properties of the mouse patellar tendon with changes in biglycan gene expression.
Dourte LM, Pathmanathan L, Mienaltowski MJ, Jawad AF, Birk DE, Soslowsky LJ.
J Orthop Res 31(9):1430-7. doi: 10.1002/jor.22372. Epub 2013 Apr 16. 2013
10BGN
Glycosaminoglycan chains of biglycan promote bone morphogenetic protein-4-induced osteoblast differentiation.
Ye Y, Hu W, Guo F, Zhang W, Wang J, Chen A.
Int J Mol Med 30(5):1075-80. doi: 10.3892/ijmm.2012.1091. Epub 2012 Aug 9. 2012
11BGN
Biglycan is an extracellular MuSK binding protein important for synapse stability.
Amenta AR, Creely HE, Mercado ML, Hagiwara H, McKechnie BA, Lechner BE, Rossi SG, Wang Q, Owens RT, Marrero E, Mei L, Hoch W, Young MF, McQuillan DJ, Rotundo RL, Fallon JR.
J Neurosci 32(7):2324-34. doi: 10.1523/JNEUROSCI.4610-11.2012. 2012
12BGN
Role of glycosaminoglycans of biglycan in BMP-2 signaling.
Miguez PA, Terajima M, Nagaoka H, Mochida Y, Yamauchi M.
Biochem Biophys Res Commun 405(2):262-6. Epub 2011 Jan 8. 2011
13BGN, DCN
Genetic evidence for the coordinated regulation of collagen fibrillogenesis in the cornea by decorin and biglycan.
Zhang G, Chen S, Goldoni S, Calder BW, Simpson HC, Owens RT, McQuillan DJ, Young MF, Iozzo RV, Birk DE.
J Biol Chem 284(13):8888-97. Epub 2009 Jan 9. 2009
14BGN, DCN
Genetic evidence for key roles of decorin and biglycan in dentin mineralization.
Haruyama N, Sreenath TL, Suzuki S, Yao X, Wang Z, Wang Y, Honeycutt C, Iozzo RV, Young MF, Kulkarni AB.
Matrix Biol 28(3):129-36. Epub 2009 Feb 12. 2009
15BGN, WISP1
The potential functional interaction of biglycan and WISP-1 in controlling differentiation and proliferation of osteogenic cells.
Inkson CA, Ono M, Bi Y, Kuznetsov SA, Fisher LW, Young MF.
Cells Tissues Organs 189(1-4):153-7. Epub 2008 Aug 14. 2009
16BGN
Biglycan is required for adaptive remodeling after myocardial infarction.
Westermann D, Mersmann J, Melchior A, Freudenberger T, Petrik C, Schaefer L, Lüllmann-Rauch R, Lettau O, Jacoby C, Schrader J, Brand-Herrmann SM, Young MF, Schultheiss HP, Levkau B, Baba HA, Unger T, Zacharowski K, Tschöpe C, Fischer JW.
Circulation 117(10):1269-76. Epub 2008 Feb 25. 2008
17BGN
Biglycan is a positive modulator of BMP-2 induced osteoblast differentiation.
Mochida Y, Parisuthiman D, Yamauchi M.
Adv Exp Med Biol 585:101-13. No abstract available. 2006
18ADGRG1, ALG5, APLP2, B3GNT3, BGN, C14orf1, CD151, CD99, CDH1, CDH32, CLPTM1, CNPY3, DAG1, DHX8, FXYD5, GDF15, HSP90B1, HSPA5, KRTCAP2, LAMA3, LMAN2, LYPD3, SPINT2, TEX261, TNFRSF12A
Identification of novel genes for secreted and membrane-anchored proteins in human keratinocytes.
Bonkobara M, Das A, Takao J, Cruz PD, Ariizumi K.
Br J Dermatol 148(4):654-64. 2003
19BGN
Biglycan isoforms with differences in polysaccharide substitution and core protein in human lung fibroblasts.
Tufvesson E, Malmstrom J, Marko-Varga G, Westergren-Thorsson G.
Eur J Biochem 269(15):3688-96. 2002
20BGN, DCN, EPYC, FMOD, KERA, LUM, OMD, PRELP, OGN
Super-motifs and evolution of tandem leucine-rich repeats within the small proteoglycans--biglycan, decorin, lumican, fibromodulin, PRELP, keratocan, osteoadherin, epiphycan, and osteoglycin.
Matsushima N, Ohyanagi T, Tanaka T, Kretsinger RH.
Proteins 38(2):210-25. 2000
21BGN
Correlation between induction of expression of biglycan and mineralization by C-type natriuretic peptide in osteoblastic cells.
Inoue A, Hayakawa T, Otsuka E, Kamiya A, Suzuki Y, Hirose S, Hagiwara H.
J Biochem (Tokyo) 125(1):103-8. 1999
22BGN
Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice.
Xu T, Bianco P, Fisher LW, Longenecker G, Smith E, Goldstein S, Bonadio J, Boskey A, Heegaard AM, Sommer B, Satomura K, Dominguez P, Zhao C, Kulkarni AB, Robey PG, Young MF.
Nat Genet 20(1):78-82. 1998
23BGN
The X-chromosomal human biglycan gene BGN is subject to X inactivation but is transcribed like an X-Y homologous gene.
Geerkens C, et al.
Hum Genet 96 : 44-52. 1995
24BGN, RPL10
Use of a radiation-reduced hybrid panel for the localization of seven markers in the Xq28 region of the human genome.
Smahi A, et al.
Ann Genet 37 : 11-13. 1994
25BGN, CDPX2A, DKC1, IP2
Mutational analysis of the biglycan gene excludes it as a candidate for X-linked dominant chondrodysplasia punctata, dyskeratosis congenita, and incontinentia pigmenti.
Das S, et al.
Am J Hum Genet 54 : 922-925. 1994
26BGN
Dinucleotide repeat polymorphism at the human biglycan (BGN) locus.
Just W, et al.
Hum Mol Genet 3 : 2268. 1994
27BGN, DCN, FMOD
Single-strand conformation polymorphism analysis of human decorin, biglycan and fibromodulin cDNAs.
Sztrolovics R, et al.
Matrix Biol 14 : 307-312. 1994
28BGN, CDPX2A, CDPX2B
Exclusion of the biglycan (BGN) gene as a candidate gene for the Happle syndrome, employing an intragenic single-strand conformational polymorphism.
Traupe H, et al.
Hum Genet 91 : 89-90. 1993
29BGN
Fine mapping of the human biglycan (BGN) gene within the Xq28 region employing a hybrid cell panel.
Traupe H, et al.
Genomics 13 : 481-483. 1992
30BGN
Human biglycan gene. Putative promoter, intron-exon junctions, and chromosomal localization.
Fisher LW, et al.
J Biol Chem 266 : 14371-14377. 1991
31DCN, BGN
In situ localization of decorin and biglycan on chromosomes 12 and X.
Just W, et al.
(HGM11) Cytogenet Cell Genet 58 : 1977. 1991
32DCN, BGN
Localization of PGI (Biglycan, BGN) and PGII (Decorin, DCN, PG-40) genes on human chromosomes Xq13-qter and 12q, respectively.
McBride OW, et al.
Genomics 6 : 219-225. 1990